The clinical application of T-cells genetically engineered to express a chimeric antigen receptor (CAR) targeting CD19 is challenged by CD19 negative relapse in B-cell acute lymphoblastic leukaemia (B-ALL). Dual (CD19 ...

The characterization of the small transcriptome reveals a generalized down-regulation both at premanifest and manifest stages, which brings out the course of Huntington’s disease. Partial Least Squares Discriminant Analysis ...

The goal of this project is to develop a system able to control the movement of a parallel platform according to the external forces applied to it. The project includes 1) the Gough-Steward parallel robot, created and ...

Lewy body diseases (LBDs) are a group of neurodegenerative diseases that consists of Parkinson’s disease, Parkinson’s disease with dementia (PD), and dementia with Lewy bodies. LBDs are characterized by the aggregation of ...

El càncer de mama és el segon més comú en la població mundial, però els tractaments quimioterapèutics actuals han mostrat reaccions adverses i fenòmens de multiresistència, essent aquest últim principalment degut a ...

Sleep is increasingly recognized as a critical component of healthy development. To better understand the impact of daily physical activity on sleep behaviour, new tools are needed. This project aims to develop an algorithm ...

ancer is a complex disease caused by the abnormal behavior and interaction of different bio entities (e.g., genes, proteins and epigenetic factors), which are profiled using omics technologies (e.g., transcriptomics, ...

Intoduction: Metastasis is associated with around the 90% of all deaths related with cancer. In metastasis, cancer cells can dissociate from the primary tumour mass and invade surrounding tissues, in a process called ...

Aquest estudi presenta els resultats de l’anàlisi de l’efecte de la kanamicina, gentamicina i neomicina en els neuromasts dels caps de larves de peix zebra de 6 dies. L’objectiu principal és trobar la concentració de ...

En aquest treball es busca la validació d’un mètode d’HPLC per a dos productes d’una empresa farmacèutica (DIVASA-FARMAVIC, S.A.) que contenen dues glicoproteïnes d’interès terapèutic. Fins ara, per poder passar els productes ...